𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Non-HFE–related hemochromatosis: The role of genetic factors

✍ Scribed by Agustin Castiella; Eva Zapata; Pedro Otazua; Leire Zubiaurre; Javier Fernandez

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
304 KB
Volume
51
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis

After reading the article by Taura et al. with great interest, we really appreciate the ingenious work they have done. 1 In this study, they found type I collagen-producing cells do not originate from hepatocytes in a triple transgenic mouse model. Hepatocytes in vivo neither express mesenchymal markers nor exhibit a morphological change. All these results strongly challenge the earlier concept that hepatocytes in vivo acquire a mesenchymal phenotype through epithelial-mesenchymal transition (EMT) to produce the extracellular matrix (ECM), leading to liver fibrosis. Although they have provided solid evidence to show that EMT does not contribute to ECM in the process of liver fibrosis, several issues need to be further discussed.

The EMT phenomenon was first clearly demonstrated by Kaimori 2 and Zeisberg 3 simultaneously in mouse liver fibrosis. Although Taura et al. challenge the concept in vivo, the three groups independently showed that isolated primary hepatocytes exhibited fibroblast-like morphological change. Therefore, the different biological behaviors of hepatocytes in liver fibrosis between in vivo and in vitro models need to be reassessed. Studies on gene expression profiles of activated hepatic stellate cells revealed the

📜 SIMILAR VOLUMES

Hemochromatosis in Italy in the last 30
Hemochromatosis in Italy in the last 30 years: Role of genetic and acquired factors
✍ Anna Ludovica Fracanzani; Alberto Piperno; Luca Valenti; Mirella Fraquelli; Sabi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB

The clinical presentation of hereditary hemochromatosis has changed markedly in recent years. The aim of this study was to analyze a large series of consecutive Italian patients with hemochromatosis diagnosed between 1976 and 2007 to determine whether the genetic background and the presence of acqui

Factors affecting the rate of iron mobil
Factors affecting the rate of iron mobilization during venesection therapy for genetic hemochromatosis
✍ Adams, Paul C. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 2 views

Although progressive iron accumulation is a characteristic feature of genetic hemochromatosis, the factors affecting the rate of iron mobilization by venesection have not been established. Venesection records were analyzed in 77 hemochromatosis homozygotes to study the factors affecting the rate of

A phase 1/2, dose-escalation trial of de
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis
✍ Pradyumna Phatak; Pierre Brissot; Mark Wurster; Paul C Adams; Herbert L. Bonkovs 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB 👁 1 views

Hereditary hemochromatosis (HH) is characterized by increased intestinal iron absorption that may result in iron overload. Although phlebotomy is widely practiced, it is poorly tolerated or contraindicated in patients with anemias, severe heart disease, or poor venous access, and compliance can vary